The ISRCTN registry is pleased to announce a partnership with the Health Research Authority (HRA). All CTIMPs (and later, all interventional studies) in the UK that receive a favourable REC opinion will be registered on ISRCTN using data from the HRA’s systems, meaning that trialists and sponsors will not have to apply for registration separately. Please see the HRA’s combined review guidance and our statement. If you have any queries, please contact us at info@isrctn.com.
The ISRCTN registry is a primary clinical trial registry recognised by WHO and ICMJE that accepts all clinical research studies (whether proposed, ongoing or completed), providing content validation and curation and the unique identification number necessary for publication. All study records in the database are freely accessible and searchable.
ISRCTN supports transparency in clinical research, helps reduce selective reporting of results and ensures an unbiased and complete evidence base.
ISRCTN accepts all studies involving human subjects or populations with outcome measures assessing effects on human health and well-being, including studies in healthcare, social care, education, workplace safety and economic development. The registry welcomes submissions in English from any location. Studies should ideally be registered prospectively (before recruitment starts). ISRCTN also accepts studies registered retrospectively once they are underway or after completion.
Investigating point of care diagnostic strategies to optimize the rapid diagnosis of COVID-19 in routine public and private health care settings in South Africa
A prospective investigation of the concordance of smartphone-based self-monitoring, imaging, and blood-based biomarkers with clinical disability in patients with multiple sclerosis within the TONiC program
Informal labour markets and decentralised solid waste management in urban areas
.png){kind=spacer}
.png){kind=spacer}
.jpg){kind=spacer}
